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Methods 29
We performed baseline and two-years follow-up on (i) 13 relapsing-remitting MS pa-30 tients and (ii) four healthy controls. A group consisting of up to 65 healthy controls was 31 used to compute the reference distribution of qMRI metrics in healthy tissue. All sub-32 jects underwent 3T MRI examinations including T1, T2, T2* relaxation and Magnetiza-33 tion Transfer Ratio (MTR) imaging. We used a recent partial volume estimation algo-34 rithm to estimate the concentration of different brain tissue types on T1 maps; then, we 35 computed a deviation map (z-score map) for each contrast at both time-points. Finally, 36
we subtracted those deviation maps only for voxels showing a significant difference with 37 healthy tissue in one of the time points, to obtain a difference map for each subject. 38
Results and Conclusion 39
Control subjects did not show any significant z-score deviations or longitudinal z-score 40 changes. On the other hand, MS patients showed brain regions with cross-sectional and 41 longitudinal concomitant increase in T1, T2, T2* z-scores and decrease of MTR z-42 scores, suggesting brain tissue degeneration/loss. In the lesion periphery, we observed 43 areas with cross-sectional and longitudinal decreased T1/T2 and slight decrease in T2* 44 most likely related to iron accumulation. Moreover, we measured longitudinal decrease 45 in T1, T2 -and to a lesser extent in T2* -as well as a concomitant increase in MTR, 46 suggesting remyelination/repair. 47
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A N U S C R I P T jects were excluded due to motion, distortion and other artifacts seen in at least one of 141 the contrasts used in the study (see Table I ). 142
The baseline and longitudinal personalized maps were computed for the 13 RRMS pa-143 tients and four healthy subjects (2 women / 2 men; age 34.5 ± 7.5 years), who were 144 randomly chosen out of the control group (HC) . 145 The healthy distribution (HD) of each contrast's parametric map used for reference was 146 computed from the remaining 16 healthy controls (10 women / 6 men; age 32 ± 10 147 years). An additional healthy distribution from 65 controls (42 women / 23 men; age 148 51.68 ± 3.46 years) was used to calculate a reference for qT1 maps as stated above 149 (HD2, Table 1 ). The four healthy subjects selected as a control test group for the com-150 putation of the personalized deviation map were not part of the group of controls used to 151 calculate the healthy distribution. 152 
All subjects underwent MRI examinations in a 3T Magnetom Trio (Siemens Healthcare, 158
Erlangen, Germany) using the following protocol: (1) High-resolution magnetization-159 prepared acquisition with gradient echo (MPRAGE); (2) 3D fluid attenuated inversion 160 recovery (3D FLAIR); (3) 3D double inversion recovery (3D DIR); (4) Magnetization-161 Prepared 2 Rapid Acquisition Gradient Echoes MP2RAGE (Marques et al., 2010) for 162 lesion identification and T1 relaxometry maps; (5) T2* relaxation using a prototype Gra-163 dient-Recalled-Echo (GRE) sequence with and without magnetization transfer (MT) 164 preparation pulse (flip-angle 220°, duration = 4000 ms; pulse offset = 2000 Hz; spoiler 165 moment 25,000 μs x mT/m (Helms and Hagberg, 2009) ). MTR maps were derived from 166 the T2* data using the following formula: 167
With M 0 and M T the images acquired without and with MT pulse, respectively. MTR was 168 computed for each echo and averaged over all echoes. Finally, (6) T2 relaxation ob-169 tained using a prototype 2D Carr-Purcell-Meiboom-Gill (CPMG) sequence with a no n-170 linear inverse reconstruction algorithm that directly estimates a T2 and spin-density map 171 from a train of undersampled spin echoes (Sumpf et al., 2011) . The acquisition of T2 172 relaxometry maps was performed with a lower spatial resolution than the one achieved 173 for the other MRI contrasts. 174
Sequence's parameters are summarized in Table II . Visual inspection of image quality 175 was performed in all cases. 176 
Personalized qMRI analysis 181
The proposed method relies on a voxel-to-region comparison, calculating a deviation 182 score (i.e. a z-score) between (i) the MR metric of the input image in each voxel and (ii) 183 the MR metric distribution of the corresponding healthy tissue of the same brain region. 184
To test the sensitivity of each parametric map to detect neuroinflammatory or neuro-185 degenerative processes, the personalized maps were computed over the T1, T2 and 186
T2* relaxation and MTR maps. 187
The condition that should be fulfilled to minimize biases is that at least one contrast 188 should provide sufficient detailed structural information in order to quantify the concen-189 tration of each brain tissue-type, which is done to minimize PVE. 190
The overall methodology can be summarized as follows: 191 Steps (2) and (3) were computed using only the uniform (UNI) image from MP2RAGE. 202
Step (4) was computed on the UNI (MP2RAGE), 3D FLAIR and DIR contrasts. An addi-203 tional affine transformation to UNI image was added for the T2, T2* and MTR contrasts 204 in order to map segmentation masks and tissue concentration maps (the masks and 205 tissue concentration maps were computed only over the T1 maps, since they are more 206 sensitive to differences between brain tissue types than other maps; see section 2.3.2). 207
All data outputs were inspected at all processing steps to assure the accuracy of vol-208 ume estimation, alignment of multi-modal MRI and fusion with lesion maps. Note that no 209 registration is needed if only one contrast is used and the tissue characterization using 210 the PVE is done over the same contrast. The following paragraphs provide a compre-211 hensive description of these steps. 212
Data preprocessing 213
A C C E P T E D M A N U S C R I P T Tissue segmentation was performed over the UNI MP2RAGE image (in patient space) 218 using the Morphobox prototype, a software based on variational expectation-219 maximization tissue classification (Roche et al., 2014; Schmitter et al., 2015) . The same 220 algorithm parcellated the brain in four main lobes: parietal, frontal, occipital and tem-221 poral (from now our regions-of-interest, ROIs), as well as the DGMN (thalamus, cau-222 date, putamen and globus pallidus, see Supplementary Information section, SI.1, for an 223 example of ROIs segmentation). 224 225
Tissue concentration estimation for partial volume correction 226
In many brain regions, especially at the border between different brain tissues, MRI in-227 tensities suffer from the so-called PVE, i.e. the imaging voxels contains more than one 228 tissue type, yielding a signal equal to the weighted average of its components. To ac-229 count for this effect in our analysis, we estimated the concentration of GM, WM and 230 CSF in each of these neighboring voxels, assigning value computed as a mixture of tis-231 sues instead of assigning them a single tissue type. This was done by applying a PVE 232 algorithm that was proposed by Roche and Forbes (Roche et al., 2014) , which relies on 233 continuous Markov Random Field (MRF) models, with the tissue concentration estima-234 tion formulated as a Bayesian maximum a posterior (MAP). This algorithm specifically 235 uses a model that describes the intensity of each voxel (y) as the sum of GM, WM and 236
where μ GM, μ WM, μ CSF are the characteristic intensities of each tissue and C GM, C WM, C CSF 239 are the concentrations of GM, WM, and CSF respectively. ε is the additive Gaussian 240 noise (with zero mean and σ standard deviation). 241
In order to solve this ill-posed problem, we set three hyper-parameters to regularize the 242 following assumptions on brain tissue intensities: (i) voxels with mild partial volume are 243 more frequent than those with strong partial volume; (ii) tissue concentration maps are 244 spatially smooth; and (iii) mean tissue intensities are bounded (see SI.2 section for 245 more details). 246
The algorithm proceeds iteratively until convergence. Once the characteristic intensities 247 μ GM , μ WM , μ CSF are initialized, the algorithm estimates the tissue concentrations C GM , 248 C WM , C CSF (step 1) and the characteristic intensities μ GM , μ WM , μ CSF (step 2) as well as 249 the noise standard deviation, σ. These steps are repeated until the cost function of the 250 algorithm converges below a defined threshold (see SI, for summary description of the 251 PVE method). The algorithm outputs three concentration maps, one for each tissue 252 (GM, WM and CSF) and the characteristic intensity values for GM, WM and CSF (see 253 Figure 1A and B for WM and GM concentration maps [cmap] 
examples). 254
Since T1 maps are more sensitive to differences between brain tissue types than other 255 maps, we performed the tissue concentration estimation on quantitative T1 maps: we 256 initialized the mean intensities at 1350 ms for the GM and 850 ms for WM, which are 257 the characteristic mean relaxation times according to (Marques et al., 2010) . In addition, 258
we applied the algorithm on each ROI separately to consider the variability of T1 signal
the subjects' T1 map space (intra-subject registration) to use tissue concentrations 261 maps estimated from the T1 contrast. To do this, we estimated an affine transformation 262 from the T2 and T2* map space (which is the same than the MTR space) to the T1 map 263 space using Elastix c++ library (Klein et al., 2010) . 264
Lesion segmentation and lesion tissue identification 265
Brain lesions were manually counted by consensus between an expert neurologist and 266 radiologist the in the 3DFLAIR, DIR and MP2RAGE uniform images as previously per-267 formed (Bonnier et al., 2014; Bonnier et al., 2015; Kober et al., 2012; Romascano et al., 268 2015) . A trained technician generated manual contours for each lesion in the three dif-269 ferent contrasts. In order to maximize the sensitivity of lesion count and volume, the 270 masks of segmented lesions in each contrast (3D FLAIR, DIR and MP2RAGE) were 271 then merged in a single "union lesion mask" as in (Bonnier et al., 2014; Bonnier et al., 272 2015; Kober et al., 2012; . Lesion volumes were computed and 273 normalized by total intracranial volume as obtained using an in-house software and 274 classified as WM, GM or mixed lesions. The lesion union mask and the ROIs masks 275 were then registered to the T1, T2, T2*, and MTR maps. 276
The method used to estimate tissue concentration is robust to subtle signal intensity 277 variations, but fails when tissue damage drastically changes MR signal like in brain le-278 sions and their vicinity. In that case, the algorithm identifies altered WM as a mix of WM 279 and GM (or even CSF). Thus, we a posteriori modified the concentration maps inside 280 brain lesions, based on a single hypothesis: there is no GM inside WM. Specifically, we 281 attributed (i) 100% WM concentration to a voxel belonging to a pure WM lesion, (ii)
lesions were manually segmented, we have also integrated a software for automated 285 lesion detection in the pipeline (Fartaria MJ, 2017a, b) . 286
Additionally, we performed morphological operations on the white matter concentration 287 map to apply the a-priori knowledge that there is no GM in the WM: first, we binarized 288 the WM concentration map by thresholding it (we use a high threshold in order to keep 289 voxels with partial volume (GM/WM border) out of the process). Then we filled the holes 290 inside the WM binary map and finally combine the binary map with original WM concen-291 tration map (see Figure 1C) . 292 
Computation of healthy tissue distribution for each qMRI map 298
T1, T2, T2* and MTR metrics vary depending on the underlying microstructure in the 299 subjects and therefore exhibit different values across the brain (Aubert-Broche et al., 300
2009; Wansapura et al., 1999) . However, these parameters are considered relatively 301 homogeneous within each cerebral lobe (Georgiades et al., 2001; Hasan et al., 2012) . 302
For each qMRI contrast, we estimated a healthy tissue distribution for each brain lobe 303 (frontal, parietal, occipital and temporal). We used a cohort of 65 healthy controls to 304 compute the reference healthy tissue distribution for the T1 parametric maps and 15 305 controls for the other parametric maps in each brain tissue (WM, GM, and CSF) and 306
ROI. 307
For each control, we first segmented the brain into WM, GM and CSF tissues as well as 308 in four different lobes (ROIs) (section 2.3.1) and then estimated their tissue concentra-309 tions separately (section 2.3.2). For each control subject and ROI, only voxels with at 310 least 95% concentration of the same tissue (WM or GM) were considered. To estimate 311 the data's statistics (mean, standard deviation and covariances) considering intra-and 312 inter-subjects variability, for each ROI we performed a bootstrapping analysis on the 313 entire healthy controls cohort. In this context, we consider the data statistics (mean and 314 standard deviation values) derived from the healthy distribution as being reasonably 315 representative of the distribution, so that the z-score (used as a measure of deviation) 316
shows abnormal brain tissue microstructure (see SI.3). 317
Deviation maps 318
The personalized deviation maps were computed by comparing the intensity of a single 319 voxel in the patient scalar map with the corresponding tissue type (WM, GM or mixed) 320 and brain ROI (frontal, parietal, temporal or occipital) value in the reference healthy di s-321 tribution. The mean and standard deviation values derived from the healthy distribution 322 of each single parameter in each ROI was considered as being reasonably representa-323 tive of the distribution, so that each deviation from "healthy tissue properties" may be
where Z V is the z-score for a single voxel, Iv is the intensity of voxel v, μ is the mean of 326 the healthy distribution over the 15 controls, and σ its standard deviation. This expres-327 sion of the z-score can be extended to a more general approach taking inn considera-328 tion the different tissue concentrations. In this case, the z-core per each voxel can be 329 re-written as: 330 
Statistical analysis 344
Each deviation map quantifies the parametric variation representative of the changes 345 occurring in an individual brain compared to a distribution of healthy controls. Thus, in 346 order to highlight both focal and diffuse brain changes at baseline and two-years follow 347 up, we first computed the deviation maps over the four quantitative MR contrasts (T1, 348 T2, T2* and MTR) for both RRMS subjects and the HC group. Then, we analyzed the 349 mean z-scores inside all voxels in all patients (i) within the lesions, (ii) in the lesions vi
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The classification of "pathological" z-scores was performed based on a previous work 353 (G. Bonnier, A. , where we MS lesions were classi-354 fied into 3 groups as follows: (i) z very low (z < −2), (ii) z very high (z > 2), and (iii) z 355 close to the HC distribution (−2 ≤ z ≤ 2), considering the continuous distribution (without 356 distinct cluster) of lesions z-scores in each contrast: these thresholds were chosen 357 based on the fact that in a normal distribution more than 95 percent of the z-scores be-358 longs to the interval [−2, 2] and that values beyond this interval reflect significant differ-359 ences in patients compared to controls (P < 0.05). 360
For the longitudinal analysis, we computed difference maps (between the z-score maps 361 obtained from the T1 map acquired at baseline and the ones obtained at 2-years follow-362 up) to show focal and diffuse brain changes. 363
RESULTS 364
Healthy tissue distribution 365
The assessment of the distribution of the T1, T2, T2* and MTR maps in our group of 366 healthy controls validate the hypothesis of a reasonably normal distribution of MRI in-367 tensities in all four lobes (see supplementary information, section SI.3). Interestingly, the 368 standard deviation (σ) of the intensities in the voxels within the different lobes of the 369 healthy tissue distribution appear higher in GM than WM for all qMRI metrics (σ GM,T1 = 370 160 ms; σ GM,T2 = 16 ms; σ GM,T2* = 22 ms; σ GM,MTR = 0.04 ms; σ WM,T1 = 60 ms; σ WM,T2 = 371
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T1 deviation maps 374
The 4 healthy controls exhibited a much lower T1 deviation in WM than patients in 375 NAWM tissue (controls: z T1 0.04 ± 0.20 vs. RRMS patients: z T1 0.50 ± 0.10 [mean ± 376 standard deviation, SD]), Figure 3A . 377
Compared to controls, the T1 deviation maps of RRMS patients showed: (i) a strong 378 increase in T1 z-score in lesions (z T1 : 4.30 ± 1.60 [mean ± SD], Figure 3B 
399
Also, MS lesions in the T1 deviation maps often appeared to be larger than the manual-400 ly segmented lesions (Figure 6 ). This was most probably due to areas of increased T1 401 relaxation times surrounding MS lesions that were not perceived as lesion tissue by our 402 neurologist and radiologist experts. 
407
Finally, the z-score map inside some large lesions revealed presence of "core" of in-408 creased T1 relaxation time where the z-score is even higher than in the rest of the le-409 sion (Figure 7) . 
Longitudinal analysis 442
In patients, some subcortical areas, predominant in the fronto-parietal lobes, showed a 443 concomitant increase in T1, T2, T2* z-scores and decrease of MTR z-scores over two 444 years ( Figure 10, A and C) . In the lesion periphery, some areas e exhibited a decrease 445 in T1/T2 and slight decrease of T2* z-scores (Figure 10, A and B) . Besides, other areas 446 showed a decrease in T1, T2 (T2*) and a concomitant increase in MTR (Figure 10, B) . To test the sensitivity and robustness of our method in the detection of subtle pathologi-458 cal brain changes, we have applied it to a longitudinal dataset of early-stage RRMS pa-459 tients, who were imaged using four quantitative and semi-quantitative contrasts (T1, T2, 460 T2*, MTR). Those contrasts/metrics were chosen because their combination has been 461 previously proven to increase sensitivity and specificity to pathological brain changes 462 related to inflammation and degeneration compared to single contrast/metric approach-463 es (Bonnier et al., 2014; Bonnier et al., 2015; Romascano et al., 464 2015) . 465
When both RRMS and control subjects were analyzed at baseline, the proposed meth-466 od was able to detect deviation from "normative ranges" (computed as healthy tissue 467 characteristic intensity obtained from healthy subjects) for RRMS subjects, while no sig-468 nificant deviations were found for our control test group. These differences were espe-469 cially remarkable within MS lesions and their vicinity but were also sometimes evident in 470 the remaining normal-appearing tissue. (Bruck et al., 2002; Lassmann et al., 2001; Lucchinetti and Bruck, 481 2004; Metz et al., 2014) . 482
In the normal appearing tissue, the highest T1 z-scores were measured in the regions 483 surrounding MS lesions, as previously reported (Bonnier et al., 2014; Davies et al., 484 2007; Parry et al., 2002; Seewann et al., 2009; Vrenken et al., 2010; West et al., 2014) , 485 (Figure 3, 5) . Increased T1 relaxation times point at a loss of tissue microstructural 486 damage and/or to an increase in iron content in the tissue (Bonnier et al., 2017; Bonnier 487 et al., 2014; Bonnier et al., 2015; , which are visible also in the ab-488 sence of macroscopic global or localized changes in brain volume (Bonnier et al., 2017; 489 Bonnier et al., 2014) . 490
The remaining NA tissue showed mild T1 increases compared to the healthy population 491 of references and interestingly, NAGM showed lower deviation of T1 relaxation times 492 compared to healthy tissue than NAWM. This may be due to the presence of a lower 493 degree of tissue damage in GM than WM at early disease stages, which is consistent 494 with previous studies (Davies et al., 2007; Klaver et al., 2013; Muhlau et al., 2013) . Yet, 495 this may also be due to higher PVE, which induces a higher variability when computingA C C E P T E D M A N U S C R I P T structural pathology that is not related to lesion load. Therefore, the personalized maps 500 of tissue damage -obtained with the proposed methodology-may help to better depict 501 the global damage provoked by MS disease, beyond the areas of focal lesions. 502
On the other hand, the deviation maps obtained from T2, T2* and MTR maps showed 503 brain tissue alterations which were located in the same regions as the ones obtained 504 from T1 maps (Figure 8 ). Yet, while the T2 and T2* deviation maps highlighted more 505 diffuse changes in patient white matter and grey matter tissue, the MTR deviation maps 506 mainly revealed focal changes in lesions (Figure 8 ). Lesion and normal-appearing tissue 507 z-score deviations were positive for T2, T2* maps and negative for MTR maps ( Figure  508 9), which is compatible with (i) tissue degeneration/loss (in the presence of concomitant 509 and strong increase in T1) or (ii) inflammatory phenomena (in the presence of less pro-510 nounced increase in T1 and/or concomitant increase in T2/T2*). 511
Nonetheless, the z-scores measured in T2, T2* and MTR maps were less important 512 than the ones revealed by T1 maps: this may be due to the lower spatial resolution of 513 the T2, T2* and MTR maps, which translates in an increase of partial volume effect, but 514 also to a higher variability of the healthy distribution compared to the pathological effect 515 on the T2 and T2* relaxation times. 516
Longitudinal analysis of parametric deviation maps showed no changes in control sub-517 jects but areas of z-score alterations in patients. Specifically, in RRMS patients, we 518 have evidenced regions with a concomitant increase in T1, T2, T2* z-scores and de Bonnier et al., 2014; Deoni, 2011; Filippi and Agosta, 2007) . Also, in the le-521 sion periphery, we could observe areas with decreased T1/T2 and slight decrease of 522 T2* indicating iron accumulation (Dusek et al., 2013) . Moreover, in other areas, we as-523 sessed longitudinal decrease in T1, T2 (T2*) and a concomitant increase in MTR oc-524 curs, suggesting remyelination/repair (Mallik et al., 2014) , Figure 10 . 525
In summary, we have developed and assessed a method that provides a whole-brain 526 personalized information of brain tissue damage and showed its sensitivity to diffuse 527 and focal changes in MS patients, both cross-sectionally and longitudinally. One ad-528 vantage of the proposed method compared to conventional voxel-based morphometry is 529 that the maps are computed in patient space, therefore bypassing all limitations of inter-530 subject registration (Klein et al., 2010) . Another advantage is the fact that it may be 531 easily extended to other type of images, provided that a large number of healthy sub-532 jects are also imaged with the same settings. Also, the proposed approach may be easi-533 ly extended to other neurological diseases since the applied metrics are sensitive to 534 neurodegenerative and neuroinflammatory changes also in other neurological disorders 535 such as mild cognitive impairment , neuroHIV infection 536 (Granziera et al., 2013) and migraine (Granziera et al., 2014) . 537
The proposed method may still benefit of a number of targeted improvements. Indeed, 538 the healthy cohort of reference presently consists of 65 and 15 subjects, who are rea-539 sonably but not perfectly representative of the healthy distribution of each metric. Be-540 cause of this, the presented results require confirmation using a larger reference cohort 541 of healthy controls, which may reduce the variability of the intensity distribution, inA C C E P T E D M A N U S C R I P T ed by the presence of stimulated echoes. To minimize this issue, we have therefore dis-546 carded the first acquired echo (at TE=9 ms). Besides that, however, the signal sampled 547 with the remaining echoes (in the range from 20-170 ms) may be still subjected to mod-548 el violations by the different T2 contributions in individual brain voxels (MacKay, Whittal, 549 et al. 1994 , MacKay, Laule, et al. 2006 , Barta, et al. 2015 . Indeed, for a precise meas-550 urement and quantification of the different T2 components of the brain tissue, a much 551 longer acquisition and a more complex data modeling are necessary (MacKay, Whittal, 552 et al. 1994 , MacKay, Laule, et al. 2006 , Barta, et al. 2015 . Nevertheless, the applied T2 553 mapping measurement has shown high sensitivity to brain pathological changes in ne u-554 roinflammatory and neurodegenerative diseases (Bonnier et al., 2017; Bonnier et al., 555 2014; Bonnier et al., 2015; as well as high precision and reproduci-556 bility (T2 variation of <0.5 ms were reported in scan-rescan measurements and < 4ms 557 across subjects) (Hilbert, et al. 2018 ) and relatively short scan times, all characteristics 558 that render it suitable for clinical studies. Furthermore, the approach we propose uses 559 the information provided by different contrasts and metrics (i.e. T1, T2, T2* and MTR) to 560 identify pathological changes in brain tissue microstructure and this is complementing -561 to a certain extent -the missing information derived from a mono-exponential fitting of 562 the T2 decay.
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Future work will focus on increasing the healthy control population, integrating automat-568 ic lesion detection tools in the pipeline and in the identification of the optimal threshold 569 for pathological changes in each contrast. 
